We worked with our network of leading neurologic clinics to identify eligible study participants, and enrolled more than 3,200 study participants—with over 400 of those participants donating samples on two or more occasions (longitudinal samples). To date, we've received 50 data sets from 36 different investigator studies. This represents a total of 1.08x1012 data points. These data sets contain the results of genetic/genomic analyses (including GWAS and gene sequencing studies), gene expression studies, proteomic screens, infectious agent detection studies and more.
Overview of cases by disease, treatment status, and time since diagnosis (cumulative)
|Tx Naive||Never On Treatment|
|Pending||Data Still Pending|